{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:16:58Z","timestamp":1784614618279,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470548"],"award-info":[{"award-number":["82470548"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270555"],"award-info":[{"award-number":["82270555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cgh.2024.10.036","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:02:43Z","timestamp":1734361363000},"page":"1808-1816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum Albumin and Its Trajectory Are Associated With Therapeutic Outcomes in Ulcerative Colitis"],"prefix":"10.1016","volume":"23","author":[{"given":"Jieqi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.10.036_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2024.10.036_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","article-title":"AGA Clinical Practice Guidelines on the management of mild-to-moderate ulcerative colitis","volume":"156","author":"Ko","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.10.036_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.10.036_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2022.11.034","article-title":"Albumin-hitchhiking: fostering the pharmacokinetics and anticancer therapeutics","volume":"353","author":"Famta","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.cgh.2024.10.036_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","article-title":"Inflammation and malnutrition in inflammatory bowel disease","volume":"8","author":"Massironi","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.10.036_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/ecco-jcc\/jjz031","article-title":"Rapid changes in laboratory parameters and early response to adalimumab: a pooled analysis from patients with ulcerative colitis in two clinical trials","volume":"13","author":"Hanauer","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.10.036_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231210053","article-title":"Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients","volume":"16","author":"Martins","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.cgh.2024.10.036_bib8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/ecco-jcc\/jjz083","article-title":"Hypoalbuminaemia and postoperative outcomes in inflammatory bowel disease: the NSQIP surgical cohort","volume":"13","author":"Nguyen","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.10.036_bib9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cgh.2022.08.015","article-title":"Predictors of placebo induction response and remission in ulcerative colitis","volume":"21","author":"Wong","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.10.036_bib10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1080\/00365521.2017.1339825","article-title":"Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn\u2019s disease","volume":"52","author":"Billiet","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.10.036_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ecco-jcc\/jjx146","article-title":"Exploration of predictive biomarkers of early infliximab response in acute severe colitis: a prospective pilot study","volume":"12","author":"Beswick","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.10.036_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.10.036_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.10.036_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2013.06.010","article-title":"Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.10.036_bib15","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.10.036_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1905725","article-title":"Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.10.036_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2024.10.036_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.10.036_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v078.i02","article-title":"Estimation of extended mixed models using latent classes and latent processes: the R package lcmm","volume":"78","author":"Proust-Lima","year":"2017","journal-title":"J Statist Softw"},{"key":"10.1016\/j.cgh.2024.10.036_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbad022","article-title":"Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis","volume":"6","author":"Chen","year":"2023","journal-title":"Precis Clin Med"},{"key":"10.1016\/j.cgh.2024.10.036_bib21","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.cgh.2020.09.046","article-title":"Treat to target: the role of histologic healing in inflammatory bowel diseases: a systematic review and meta-analysis","volume":"19","author":"Gupta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.10.036_bib22","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/apt.13375","article-title":"Review article: the histological assessment of disease activity in ulcerative colitis","volume":"42","author":"Marchal Bressenot","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.10.036_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.maturitas.2015.02.009","article-title":"Serum albumin and health in older people: review and meta analysis","volume":"81","author":"Cabrerizo","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.cgh.2024.10.036_bib24","first-page":"1963","article-title":"Significance of rapid turnover proteins in protein-losing gastroenteropathy","volume":"50","author":"Takeda","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2024.10.036_bib25","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.3390\/jcm12227132","article-title":"Drug clearance in patients with inflammatory bowel disease treated with biologics","volume":"12","author":"Deyhim","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.cgh.2024.10.036_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/ibd\/izac075","article-title":"Histologic activity and steroid use history are risk factors of clinical relapse in ulcerative colitis with Mayo endoscopic subscore of 0 or 1","volume":"29","author":"Seong","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.10.036_bib27","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1053\/j.gastro.2020.05.066","article-title":"Baseline disease activity and steroid therapy stratify risk of COVID-19 in patients with inflammatory bowel disease","volume":"159","author":"Lukin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.10.036_bib28","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41598-024-54332-1","article-title":"Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB","volume":"14","author":"Fr\u00f3es","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2024.10.036_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104442","article-title":"Can molecular stratification improve the treatment of inflammatory bowel disease?","volume":"148","author":"Wang","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cgh.2024.10.036_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ecco-jcc\/jjx118","article-title":"Simultaneous measurements of faecal calprotectin and the faecal immunochemical test in quiescent ulcerative colitis patients can stratify risk of relapse","volume":"12","author":"Nakarai","year":"2018","journal-title":"J Crohns Colitis"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524010917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524010917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:24:14Z","timestamp":1783034654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524010917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1542356524010917"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.10.036","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Albumin and Its Trajectory Are Associated With Therapeutic Outcomes in Ulcerative Colitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute","name":"copyright","label":"Copyright"}]}}